Schweitzer-Mauduit International, Inc. ("SWM" or the "Company")
(NYSE: SWM) reported earnings results for the three months and year
ended March 31, 2021.
Adjusted measures are reconciled to GAAP at the
end of this release. Financial and operating comparisons are
versus the prior year period. Figures may not sum to total
due to rounding. Definitions: Advanced Materials &
Structures (AMS), Engineered Papers (EP), "organic" - pro forma for
"Tekra" - Tekra and Trient acquisition that closed in March
2020.
First Quarter 2021 Financial Results
Summary
- 15% organic sales growth in AMS and strong margin performance
across both segments drove positive consolidated results
- Total sales were $288.2 million, up 10.2%
- GAAP operating profit was $33.5 million, or 11.6% of sales,
down 2%; Adjusted operating profit was $45.3 million, or 15.7% of
sales, up 14%
- GAAP EPS was $0.68, down 6%, reflected Scapa acquisition
related expenses of $0.22 per share acquisition (closed April 15,
2021); Adjusted EPS was $1.02, up 20%
2021 Financial Outlook
- The Company issued 2021 Adjusted EPS guidance of $3.75 to
$4.05, which includes $0.10 of accretion from the Scapa acquisition
for the remainder of 2021 and at least $0.50 of Adjusted EPS
accretion in 2022 as the business trends toward pre-COVID-19
performance
Management Commentary
Dr. Jeff Kramer, Chief Executive Officer,
commented, "SWM got off to a strong start to 2021, carrying forward
the positive momentum from the fourth quarter in several key areas
of the business. We leveraged a 10% sales increase into 20%
Adjusted EPS growth, with high organic sales growth in AMS and
solid execution across our operations. Our teamwork and dedication
to servicing customers remains a pillar of our success, as it has
throughout the pandemic, as demonstrated by these results. We
are also excited about the recent closing of the Scapa acquisition,
a pivotal transaction that accelerates our growth outlook by
scaling up our healthcare business, bolstering our presence in
several attractive industrial end-markets, and adding a host of new
capabilities. We are better positioned than ever to be the
supplier of choice for our global customers, as we deliver an even
greater set of essential performance materials and fully integrated
solutions."
"First quarter results were propelled by 15% organic growth in
AMS, with over 20% increases in both transportation and filtration
sales. Our leadership position in very attractive specialty
applications within these broad industries is serving us
well. For example, demand for high-end air filtration media
remains elevated and the sharp rebound in our auto paint protection
films business has continued, with each product category delivering
more than 50% growth versus last year. EP performed as we expected,
with lower volumes partially offset by efficiencies and an improved
cost structure. Heat-not-Burn products and certain other tobacco
papers showed good growth. During the quarter, we did experience
some temporary unfavorable timing impacts of customer inventory
drawdowns related to the closing of our Spotswood facility, which
should be behind us going forward."
"Looking forward, we are poised for growth in 2021 and are
excited to welcome the Scapa organization into SWM. We are a
best-in-class performance materials and solutions company with
expanded innovation and manufacturing capabilities, increased
scale, and a bright outlook. While some aspects of Scapa's
business have been previously challenged by the pandemic,
particularly the impact of reduced elective medical procedures on
its healthcare business, recent trends show many areas moving
towards more normalized levels. Longer-term we are highly
optimistic about the growth opportunities we can pursue together
and the potential to create significant value for our customers and
shareholders through this combination."
Dr. Kramer concluded "With the Scapa acquisition now closed, we
are providing 2021 Adjusted EPS guidance of $3.75 to $4.05, which
includes $0.10 of Scapa accretion, and implies high-single-digit
growth versus 2020. Consistent with our comments in February,
we expect strong sales and profit gains in AMS to offset a
reversion toward more historical levels of operating profits in EP,
as 2020 benefited from some one-time customer inventory
builds. Our guidance also reflects a cautious view on input
costs given the significant and unexpected recent increases in
resin and wood pulp and continued supply chain challenges related
to COVID-19. To offset these headwinds, we have already implemented
price increases and other measures. Regarding Scapa, the business
has been performing as we expected, and we anticipate positive
trends in 2021 as it continues to recover from COVID-19
impacts. Further, we are optimistic that 2022 will bring a
more normalized environment and dramatically improved financial
results. We look forward to onboarding the Scapa team, integrating
our businesses, capitalizing on the many opportunities across the
business, and ultimately delivering another year of robust cash
flows and earnings growth."
First Quarter 2021 Financial Results
Advanced Materials &
Structures segment sales were $163.0 million, up 33%,
including the benefit from the Tekra acquisition, while organic
sales increased 15% (acquisition closed in March 2020, organic
calculation assumes pro forma ownership for the full prior year
period). The organic sales increase was driven by rapid growth in
transportation sales as they continued to rebound sharply from
COVID-19 related pressures that began early in 2020. Filtration
sales also increased over 20%, led by air filtration products, as
well as gains across water and process filtration products.
Healthcare sales increased with gains across the portfolio,
including woundcare, facemasks, and medical packaging. Construction
sales increased, led by double-digit growth in key infrastructure
and construction applications. Industrial sales declined during the
quarter.
GAAP operating profit was $21.3 million, or
13.1% of sales, up 55%. Adjusted operating profit was $27.8
million, up 44%, with margin up 140 basis points to 17.1%. Both
GAAP and adjusted operating profit growth were driven by strong
organic sales growth and the incremental benefit of the acquired
Tekra business, partially offset by higher raw material costs,
primarily for polypropylene resin.
Engineered Papers segment sales
were $125.2 million, down 10%, driven by a 6% volume decrease and
unfavorable price/mix of 8%, which were partially offset by a 4%
currency benefit (related to the Euro). The volume decline
was primarily attributable to the continued reduction of low-margin
printing and writing products and a decrease in high-value LIP (low
ignition propensity) tobacco papers. The LIP decline was
anticipated as the Company transitioned a large customer previously
supplied from the Spotswood, NJ facility (closed during 4Q:20) to
other sites, and the customer worked through legacy inventories.
The LIP volume decline also contributed to the negative mix.
The total volume declines were partially offset by growth in
certain other specialty tobacco papers and gains in Heat-not-Burn
recon products as our customers are benefiting from increased sales
of reduced risk products.
GAAP operating profit was $29.9 million, or 23.9% of sales, down
10%. Adjusted operating profit was $31.6 million, down 6%, with
adjusted operating margin expanding 100 basis points to 25.2%.
Margins increased primarily due to cost reductions from the
Spotswood site closure, good manufacturing and operational
performance, and strong SG&A controls, partially offset by
higher wood pulp input costs. Currency movements resulted in a $1.4
million benefit to operating profit, mainly from the Euro and
Brazilian Real.
Unallocated GAAP expenses were
$17.7 million, versus $13.0 million in 1Q:20; $3.6 million of the
increase related to the Scapa acquisition and associated
third-party advisory and diligence costs. Adjusted
unallocated expenses (which excluded the Scapa acquisition related
costs) were $14.1 million, versus $13.0 million, and were 4.9% of
total sales, down 10 basis points.
Consolidated sales were $288.2
million, up 10%, or up 7% absent favorable currency movements. GAAP
operating profit was $33.5 million, down 2%, and GAAP operating
profit margin was 11.6%. Adjusted operating profit was $45.3
million, up 14%, and adjusted operating profit margin was 15.7%, up
50 basis points.
GAAP income was $21.6 million, down 4%; GAAP EPS
was $0.68; GAAP EPS was impacted by $0.22 per share of Scapa
acquisition related expenses (detailed below). Adjusted income was
$32.2 million, up 22%; Adjusted EPS was $1.02. Adjusted EBITDA was
$55.2 million, up 13%, and adjusted EBITDA margin was 19.2%, up 50
basis points.
Interest expense was $2.9 million, down from
$6.9 million, and benefited from a $4.5 million reversal of
previously accrued expenses related to Brazil tax assessments due
to a favorable settlement. Interest expense on debt was $7.4
million, up $0.5 million due to higher average debt balances as a
result of the Tekra acquisition. Other expense was $2.6 million,
versus other income of $0.6 million in the prior year quarter, due
primarily to the negative mark-to-market impact of forward currency
contracts on the British pound associated with the Scapa
acquisition to hedge currency risk of the purchase price during the
period between the transaction agreement and closing. This expense
was partially offset by other components of the favorable Brazil
tax assessment settlement.
The Company reported a tax rate of 26.4%, versus
19.1% in the prior year period. Excluding the effect of non-GAAP
adjustments, the first quarter 2021 tax rate was 20.5% (the implied
rate reflected in the Company's Adjusted EPS), versus 21.3% in the
prior year quarter.
The Company's Chinese JVs contributed $0.03 to
both GAAP and Adjusted EPS, versus breakeven in the prior year
quarter.
Net currency movements had a $1.8 million
benefit operating profits and the translation impact of net
currency movements was positive $0.01 to both GAAP EPS and Adjusted
EPS.
Non-GAAP Adjustments reflect
items included in GAAP operating profit, income, and EPS, but
excluded from adjusted operating profit, income, and EPS (see
non-GAAP reconciliation tables). The most significant adjustments
to first quarter 2021 results were $0.22 per share of expenses
related to the Scapa acquisition and included third party advisory
and diligence fees which affected GAAP operating profits and the
unfavorable mark-to-market impact of the British pound forward
contracts which affected other expense. Non-GAAP adjustments also
included purchase accounting expenses of $0.16 per share (purchase
accounting expenses reflect the ongoing non-cash intangible asset
amortization, as well as non-cash one-time inventory step-up
charges, associated with AMS acquisitions). The Company also
adjusted for the benefit related to the Brazil tax assessment
settlement, which equated to $0.11 of EPS, which had a positive
impact on interest and other expense.
Cash Flow, Debt, & Dividend
First quarter 2021 cash provided by operating
activities was $12.7 million, up $7.6 million. The Company's
working capital-related cash outflows were $30.5 million, compared
to $33.7 million in the prior year period, reflecting the Company's
typical seasonal working capital pattern.
Capital spending and capitalized software
totaled $7.6 million, down $0.5 million. Year-to-date free cash
flow was $5.1 million, up $8.1 million, due to operating profit
growth and favorable working capital movements.
Total debt was $617.9 million as of
March 31, 2021, up $24.6 million from year end 2020, and total
cash was $63.7 million; net debt was $554.2 million on
March 31, 2021, up $15.6 million. Pursuant to the terms of the
Company's credit agreement, net debt to adjusted EBITDA was 2.4x as
of March 31, 2021, versus 2.3x at year end 2020.
Subsequent to the end of the first quarter, the Company closed the
Scapa acquisition; adjusting for the transaction, the Company's net
debt to adjusted EBITDA is estimated to be approximately 4.3x.
The Company announced a quarterly cash dividend
of $0.44 per share. The dividend will be payable on June 18,
2021 to stockholders of record as of May 21, 2021.
Business Outlook
The Company issued 2021 Adjusted EPS guidance of
$3.75 to $4.05, which includes $0.10 of accretion from the Scapa
acquisition. The 2021 expected accretion from Scapa reflects
continued challenges, as anticipated, in its healthcare business as
the operations progress back toward pre-COVID performance levels.
Management expects the transaction to be at least $0.50 accretive
to Adjusted EPS in 2022.
Due to the recent timing of the Scapa
acquisition close, as well as the scope and complexity of the
accounting transition from IFRS to US GAAP and required purchase
accounting expense analyses (primarily valuation of intangible
assets), the Company is not able to estimate GAAP EPS for 2021 and
provide the associated reconciliation to Adjusted EPS guidance
without unreasonable effort.
Conference Call
SWM will hold a conference call to review first
quarter 2021 results with investors and analysts at 8:30 a.m.
Eastern time on Thursday, May 6, 2021. The earnings conference call
will be simultaneously broadcast over the Internet at
www.swmintl.com. To listen to the call, please go to the
Company’s website at least 15 minutes prior to the call to register
and to download and install any necessary audio software. For those
unable to listen to the live broadcast, a replay will be available
on the Company’s website shortly after the call.
SWM will use a presentation in conjunction with
its conference call. The presentation can be found on the
Company's website under the Investor Relations section in advance
of the earnings conference call. The presentation can also be
accessed via the earnings conference call webcast.
About SWM
SWM is a leading global performance materials company, focused
on bringing best-in-class innovation, design, and manufacturing
solutions to our customers. Our highly engineered films, adhesive
tapes, foams, nets, nonwovens, and papers are designed and
manufactured using resins, polymers, and natural fibers for a
variety of industries and specialty applications. SWM and its
subsidiaries manufacture on four continents, conduct business in
over 90 countries and employ approximately 5,000 people worldwide.
For further information, please visit SWM’s website at
www.swmintl.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 that are subject to the safe harbor created by
by that Act and other legal protections.
Forward-looking statements include, without limitation, those
regarding the incurrence of additional debt, future performance,
capital expenditures, future market and EPS trends and
guidance, sales and volume trends, growth prospects, the cost and
timing of our restructuring actions, currency rates and trends and
impact on EPS, future cash flows, purchase accounting impacts,
effective tax rates, planned investments, impacts of the
COVID-19 pandemic on our operations, profitability, and cash flow,
the expected benefits and accretion of the Scapa acquisition and
other statements generally identified by words such as "believe,"
"expect," "intend," "guidance," "plan," "forecast," "potential,"
"anticipate," "confident," "project," "appear," "future," "should,"
"likely," "could," "may," "typically," "will," and similar
words.
These forward-looking statements are prospective
in nature and not based on historical facts, but rather on current
expectations and on numerous assumptions regarding the business
strategies and the environment in which our business shall operate
in the future and are subject to risks and uncertainties that could
cause actual results to differ materially from those expressed or
implied by those statements. No assurance can be given that such
expectations will prove to have been correct and persons reading
this presentation are therefore cautioned not to place undue
reliance on these forward-looking statements which speak only as at
the date of this press release. These statements are not guarantees
of future performance and are subject to certain risks,
uncertainties (some of which are beyond the Company’s control) and
assumptions that may cause actual results to differ materially from
our expectations as of the date of this release. These risks
include, among other things, the following factors:
- Risks associated with pandemics and other public health
emergencies, including the continued spread and impact of, and the
governmental and third party response to, the COVID-19
pandemic;
- The impact of mandatory business closures, limits on
non-essential travel, “social or physical distancing” guidelines,
“shelter-in-place” mandates and similar governmental and private
measures taken to combat the spread of COVID-19;
- Changes in sales or production volumes, pricing and/or
manufacturing costs of Recon products, cigarette paper (including
for LIP cigarettes), including any change by our customers in their
tobacco and tobacco-related blends for their cigarettes, their
target inventory levels and/or the overall demand for their
products, new technologies such as e-cigarettes, inventory
adjustments and rebalancings in our EP segment. Additionally,
competition and changes in AMS end-market products due to changing
customer demands;
- Changes in the Chinese economy, including relating to the
demand for reconstituted tobacco, premium cigarettes and netting
and due to impact of tariffs;
- Risks associated with the implementation of our strategic
growth initiatives, including diversification, and the Company's
understanding of, and entry into, new industries and
technologies;
- Changes in the source and intensity of competition in our
commercial segments. We operate in highly competitive markets
in which alternative supplies and technologies may attract our
customers away from our products. In addition, our customers
may, in some cases, produce for themselves the components that the
Company sells to them for incorporation into their products, thus
reducing or eliminating their purchases from us;
- Our ability to attract and retain key personnel, due to our
prior restructuring actions, the tobacco industry in which we
operate or otherwise;
- Weather conditions, including potential impacts, if any, from
climate change, known and unknown, seasonality factors that affect
the demand for virgin tobacco leaf and natural disasters or unusual
weather events;
- Seasonal or cyclical market and industry fluctuations which may
result in reduced net sales and operating profits during certain
periods;
- Increases in commodity prices and lack of availability of such
commodities, including energy, wood pulp and resins, which could
impact the sales and profitability of our products;
- Adverse changes in the oil, gas, automotive, construction and
infrastructure, and mining sectors impacting key AMS segment
customers;
- Increases in operating costs due to inflation or otherwise,
such as labor expense, compensation and benefits costs;
- Employee retention and labor shortages;
- Changes in employment, wage and hour laws and regulations in
the U.S., France and elsewhere, including the loi de Securisation
de l'emploi in France, unionization rule and regulations by the
National Labor Relations Board in the U.S., equal pay initiatives,
additional anti-discrimination rules or tests and different
interpretations of exemptions from overtime laws;
- Labor strikes, stoppages, disruptions or other disruptions at
our facilities;
- The impact of tariffs, and the imposition of any future
additional tariffs and other trade barriers, and the effects of
retaliatory trade measures;
- Existing and future governmental regulation and the enforcement
thereof, for example relating to the tobacco industry, taxation and
the environment (including the impact thereof on our Chinese joint
ventures);
- New reports as to the effect of smoking on human health or the
environment;
- Changes in general economic, financial and credit conditions in
the U.S., Europe, China and elsewhere, including the impact thereof
on currency exchange rates (including any weakening of the Euro and
Real) and on interest rates and the effects of the ongoing
discussions between the U.K. and European Union to determine the
terms of the U.K.'s withdrawal from the European Union;
- Changes in the method pursuant to which LIBOR rates are
determined and the phasing out of USD LIBOR after 2023;
- Changes in the manner in which we finance our debt and future
capital needs, including potential acquisitions;
- The success of, and costs associated with, our current or
future restructuring initiatives, including the granting of any
needed governmental approvals and the occurrence of work stoppages
or other labor disruptions;
- Changes in the discount rates, revenue growth, cash flow growth
rates or other assumptions used by the Company in its assessment
for impairment of assets and adverse economic conditions or other
factors that would result in significant impairment charges;
- The failure of one or more material suppliers, including
energy, resin and pulp suppliers, to supply materials as needed to
maintain our product plans and cost structure;
- International conflicts and disputes, which restrict our
ability to supply products into affected regions, due to the
corresponding effects on demand, the application of international
sanctions, or practical consequences on transportation, banking
transactions, and other commercial activities in troubled
regions;
- Compliance with the FCPA and other anti-corruption laws or
trade control laws, as well as other laws governing our
operations;
- The pace and extent of further international adoption of LIP
cigarette standards and the nature of standards so adopted;
- Risks associated with our 50%-owned, non-U.S. joint ventures
relating to control and decision-making, compliance, accounting
standards, transparency and customer relations, among others;
- A failure in our risk management and/or currency or interest
rate swaps and hedging programs, including the failures of any
insurance company or counterparty;
- The number, type, outcomes (by judgment or settlement) and
costs of legal, tax, regulatory or administrative proceedings,
litigation and/or amnesty programs, including those in Brazil,
France and Germany;
- The outcome and cost of LIP-related intellectual property
infringement and validity litigation in Europe and the Glatz's
German Patent Court invalidation proceedings;
- Risks associated with our technological advantages in our
intellectual property and the likelihood that our current
technological advantages are unable to continue indefinitely;
- Risks associated with acquisitions or other strategic
transactions, including acquired liabilities and restrictions,
retaining customers from businesses acquired, achieving any
expected results or synergies from acquired businesses, complying
with new regulatory frameworks, difficulties in integrating
acquired businesses or implementing strategic transactions
generally and risks associated with international acquisition
transactions, including in countries where we do not currently have
a material presence;
- Risks associated with dispositions, including post-closing
claims being made against us, disruption to our other businesses
during a sale process or thereafter, credit risks associated with
any buyer of such disposed assets and our ability to collect funds
due from any such buyer;
- Risks associated with our global asset realignment initiatives,
including: changes in tax law, treaties, interpretations, or
regulatory determinations; audits made by applicable regulatory
authorities and/or our auditor; and our ability to operate our
business in a manner consistent with the regulatory requirements
for such realignment;
- Increased taxation on tobacco-related products;
- Costs and timing of implementation of any upgrades or changes
to our information technology systems;
- Failure by us to comply with any privacy or data security laws
or to protect against theft of customer, employee and corporate
sensitive information;
- Changes in tax rates, the adoption of new U.S. or international
tax legislation or exposure to additional tax liabilities;
- Changes in construction and infrastructure spending and its
impact on demand for certain products;
- Potential loss of consumer awareness and demand for acquired
companies’ products if it is decided to rebrand those products
under the Company’s legacy brand names; and
- Other factors described elsewhere in this document and from
time to time in documents that we file with the SEC.
All forward-looking statements made in this
document are qualified by these cautionary statements.
Forward-looking statements herein are made only as of the date of
this document, and we do not undertake any obligation, other than
as may be required by law, to update or revise any forward-looking
or cautionary statements to reflect changes in assumptions, the
occurrence of events, unanticipated or otherwise, or changes in
future operating results over time or otherwise.
Comparisons of results for current and any prior
periods are not intended to express any future trends or
indications of future performance unless expressed as such and
should only be viewed as historical data. The financial
results reported in this release are unaudited.
For additional factors and further discussion of
these factors, please see SWM's Annual Report on Form 10-K for the
year ended December 31, 2020 and other reports we file with
the SEC from time to time, which can be found at the SEC’s website
www.sec.gov. The discussion of these risks is specifically
incorporated by reference into this release. The financial results
reported in this release are unaudited.
Non-GAAP Financial Measures
Certain financial measures and comments
contained in this press release exclude restructuring and
impairment expenses, plant closure expenses, certain purchase
accounting adjustments related to AMS segment acquisitions,
interest expense, the effect of income tax provisions and other tax
impacts, capital spending, capitalized software costs, and
depreciation and amortization. This press release also
provides certain information regarding the Company's financial
results excluding currency impacts. This information
estimates the impact of changes in foreign currency rates on the
translation of the Company's current financial results as compared
to the applicable comparable period and is derived by translating
the current local currency results into U.S. Dollars based upon the
foreign currency exchange rates for the applicable comparable
period. Financial measures which exclude or include these
items have not been determined in accordance with accounting
principles generally accepted in the United States (GAAP) and are
therefore "non-GAAP" financial measures. Reconciliations of these
non-GAAP financial measures to the most closely analogous measure
determined in accordance with GAAP are included in the financial
schedules attached to this release.
The Company believes that the presentation of
non-GAAP financial measures in addition to the related GAAP
measures provides investors with greater transparency on the
information used by the Company’s management in its financial and
operational decision-making. Management also believes that
the non-GAAP financial measures provide additional insight for
analysts and investors in evaluating the Company’s financial and
operational performance in the same way that management evaluates
the Company's financial performance. Management believes that
providing this information enables investors to better understand
the Company’s operating performance and financial condition.
These non-GAAP financial measures are not calculated or presented
in accordance with, and are not intended to be considered in
isolation or as alternatives or substitutes for, or superior to,
financial measures prepared and presented in accordance with GAAP,
and should be read only in conjunction with the Company's financial
measures prepared and presented in accordance with GAAP. The
non-GAAP financial measures used in this release may be different
from the measures used by other companies.
SOURCE SWM:
CONTACT
Andrew WamserChief Financial
Officer+1-770-569-4271
Or
Mark ChekanowDirector of Investor
Relations+1-770-569-4229
Website: http://www.swmintl.com
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND
SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF
INCOME(Dollars in millions, except per share
amounts)(Unaudited)
|
Three Months Ended March 31, |
|
|
|
2021 |
|
2020 |
|
% Change |
Net sales |
$ |
288.2 |
|
|
$ |
261.5 |
|
|
10.2 |
% |
Cost of products sold |
207.4 |
|
|
187.2 |
|
|
10.8 |
|
Gross profit |
80.8 |
|
|
74.3 |
|
|
8.7 |
|
|
|
|
|
|
|
Selling expense |
9.1 |
|
|
9.5 |
|
|
(4.2) |
|
Research and development expense |
3.8 |
|
|
3.2 |
|
|
18.8 |
|
General expense |
32.7 |
|
|
27.4 |
|
|
19.3 |
|
Total nonmanufacturing expenses |
45.6 |
|
|
40.1 |
|
|
13.7 |
|
|
|
|
|
|
|
Restructuring and
impairment expense |
1.7 |
|
|
0.1 |
|
|
N.M. |
Operating
profit |
33.5 |
|
|
34.1 |
|
|
(1.8) |
|
Interest expense |
2.9 |
|
|
6.9 |
|
|
(58.0) |
|
Other (expense) income, net |
(2.6) |
|
|
0.6 |
|
|
N.M. |
Income before
income taxes and income from equity affiliates |
28.0 |
|
|
27.8 |
|
|
0.7 |
|
|
|
|
|
|
|
Provision for income taxes |
7.4 |
|
|
5.3 |
|
|
39.6 |
|
Income from equity affiliates, net of income taxes |
1.0 |
|
|
— |
|
|
N.M |
Net income |
$ |
21.6 |
|
|
$ |
22.5 |
|
|
(4.0) |
% |
|
|
|
|
|
|
Net income per
share - basic: |
|
|
|
|
|
Net income per share – basic |
$ |
0.69 |
|
|
$ |
0.72 |
|
|
(4.2) |
% |
|
|
|
|
|
|
Net income per
share – diluted: |
|
|
|
|
|
Net income per share – diluted |
$ |
0.68 |
|
|
$ |
0.72 |
|
|
(5.6) |
% |
|
|
|
|
|
|
Cash dividends
declared per share |
$ |
0.44 |
|
|
$ |
0.44 |
|
|
|
|
|
|
|
|
|
Weighted average
shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
30,974,200 |
|
|
30,712,300 |
|
|
|
|
|
|
|
|
|
Diluted |
31,340,500 |
|
|
30,910,000 |
|
|
|
N.M. - Not Meaningful
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND
SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE
SHEETS(Dollars in
millions)(Unaudited)
|
March 31, 2021 |
|
December 31, 2020 |
ASSETS |
|
|
|
Cash and cash
equivalents |
$ |
63.7 |
|
|
$ |
54.7 |
|
Accounts
receivable, net |
172.9 |
|
|
148.5 |
|
Inventories |
173.3 |
|
|
179.7 |
|
Other current
assets |
18.2 |
|
|
13.5 |
|
Property, plant
and equipment, net |
324.1 |
|
|
339.0 |
|
Goodwill |
401.8 |
|
|
403.7 |
|
Other noncurrent
assets |
433.5 |
|
|
445.8 |
|
Total Assets |
$ |
1,587.5 |
|
|
$ |
1,584.9 |
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
Current debt |
$ |
2.7 |
|
|
$ |
2.8 |
|
Other current
liabilities |
155.0 |
|
|
164.1 |
|
Long-term
debt |
615.2 |
|
|
590.5 |
|
Pension and other
postretirement benefits |
35.3 |
|
|
36.5 |
|
Deferred income
tax liabilities |
45.0 |
|
|
45.1 |
|
Long-term income
tax payable |
17.7 |
|
|
17.7 |
|
Other noncurrent
liabilities |
63.7 |
|
|
78.6 |
|
Stockholders’
equity |
652.9 |
|
|
649.6 |
|
Total Liabilities and Stockholders’ Equity |
$ |
1,587.5 |
|
|
$ |
1,584.9 |
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND
SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOW(Dollars in
millions)(Unaudited)
|
Three Months Ended March 31, |
|
2021 |
|
2020 |
Operating |
|
|
|
Net income |
$ |
21.6 |
|
|
$ |
22.5 |
|
Non-cash items included in net income: |
|
|
|
Depreciation and amortization |
16.9 |
|
|
15.3 |
|
Deferred income tax |
3.0 |
|
|
0.7 |
|
Pension and other postretirement benefits |
1.1 |
|
|
0.8 |
|
Stock-based compensation |
2.1 |
|
|
2.2 |
|
Income from equity affiliates |
(1.0) |
|
|
— |
|
Brazil tax assessment accruals, net |
(6.1) |
|
|
— |
|
Other items |
5.6 |
|
|
(2.7) |
|
Changes in operating working capital |
(30.5) |
|
|
(33.7) |
|
Cash provided by operations |
12.7 |
|
|
5.1 |
|
|
|
|
|
Investing |
|
|
|
Capital spending |
(7.1) |
|
|
(7.4) |
|
Capitalized software costs |
(0.5) |
|
|
(0.7) |
|
Acquisitions, net of cash acquired |
— |
|
|
(170.6) |
|
Other investing |
0.3 |
|
|
2.4 |
|
Cash used in investing |
(7.3) |
|
|
(176.3) |
|
|
|
|
|
Financing |
|
|
|
Cash dividends paid to SWM stockholders |
(13.8) |
|
|
(13.7) |
|
Proceeds from issuances of long-term debt |
25.0 |
|
|
212.0 |
|
Payments on long-term debt |
(0.6) |
|
|
(0.4) |
|
Payments for debt issuance costs |
(3.0) |
|
|
— |
|
Purchases of common stock |
(3.1) |
|
|
(1.0) |
|
Cash provided by financing |
4.5 |
|
|
196.9 |
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
(0.9) |
|
|
(2.0) |
|
|
|
|
|
Increase in cash
and cash equivalents |
$ |
9.0 |
|
|
$ |
23.7 |
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND
SUBSIDIARIES
BUSINESS SEGMENT REPORTING(Dollars in
millions)(Unaudited)
Net
Sales |
|
|
|
|
|
|
Three Months Ended March 31, |
|
2021 |
|
2020 |
|
% Change |
AMS |
$ |
163.0 |
|
|
$ |
122.9 |
|
|
32.6 |
% |
EP |
125.2 |
|
|
138.6 |
|
|
(9.7) |
% |
Total Consolidated |
$ |
288.2 |
|
|
$ |
261.5 |
|
|
10.2 |
% |
Operating Profit |
|
Three Months Ended March 31, |
|
|
|
|
|
Return on Net Sales |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
AMS |
$ |
21.3 |
|
|
$ |
13.7 |
|
|
13.1 |
% |
|
11.1 |
% |
EP |
29.9 |
|
|
33.4 |
|
|
23.9 |
% |
|
24.1 |
% |
Unallocated |
(17.7) |
|
|
(13.0) |
|
|
|
|
|
Total Consolidated |
$ |
33.5 |
|
|
$ |
34.1 |
|
|
11.6 |
% |
|
13.0 |
% |
Non-GAAP Adjustments to Operating Profit |
|
Three Months Ended March 31, |
|
2021 |
|
2020 |
AMS - Purchase
Accounting Adjustments |
$ |
6.5 |
|
|
$ |
5.6 |
|
EP -
Restructuring and impairment Expenses |
1.7 |
|
|
0.1 |
|
Unallocated -
Acquisition Related Costs |
3.6 |
|
|
— |
|
Total Consolidated |
$ |
11.8 |
|
|
$ |
5.7 |
|
Adjusted Operating Profit |
|
Three Months Ended March 31, |
|
|
|
|
|
Return on Net Sales |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
AMS |
$ |
27.8 |
|
|
$ |
19.3 |
|
|
17.1 |
% |
|
15.7 |
% |
EP |
31.6 |
|
|
33.5 |
|
|
25.2 |
% |
|
24.2 |
% |
Unallocated |
(14.1) |
|
|
(13.0) |
|
|
|
|
|
Total Consolidated |
$ |
45.3 |
|
|
$ |
39.8 |
|
|
15.7 |
% |
|
15.2 |
% |
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND
SUBSIDIARIESRECONCILIATION OF NON-GAAP FINANCIAL
MEASURES AND SUPPLEMENTAL DATA(Dollars in
millions, except per share amounts)
|
Three Months Ended March 31, |
|
2021 |
|
2020 |
Operating
profit |
$ |
33.5 |
|
|
$ |
34.1 |
|
Plus:
Restructuring expenses |
1.7 |
|
|
0.1 |
|
Plus: Purchase
accounting adjustments |
6.5 |
|
|
5.6 |
|
Plus: Acquisition
related costs |
3.6 |
|
|
— |
|
Adjusted
Operating Profit |
$ |
45.3 |
|
|
$ |
39.8 |
|
|
|
|
|
Income |
$ |
21.6 |
|
|
$ |
22.5 |
|
Plus:
Restructuring and impairment expense |
1.7 |
|
|
0.1 |
|
Less: Tax impact
of restructuring and impairment expense |
(0.4) |
|
|
— |
|
Plus: Purchase
accounting adjustments |
6.5 |
|
|
5.6 |
|
Less: Tax impact
of purchase accounting adjustments |
(1.6) |
|
|
(1.4) |
|
Plus: Brazil tax
assessments |
(6.1) |
|
|
— |
|
Less: Tax impact
of Brazil tax assessments |
2.7 |
|
|
— |
|
Plus: Acquisition
Related Costs |
3.6 |
|
|
— |
|
Less: Tax impact
on acquisition Related Costs |
(0.8) |
|
|
— |
|
Plus: GBP forward
contract MTM |
5.6 |
|
|
— |
|
Less: Tax Impact
on GBP forward contract MTM |
(1.3) |
|
|
— |
|
Less: Tax
legislative changes, net of other discrete items |
0.7 |
|
|
(0.3) |
|
Adjusted
Income |
$ |
32.2 |
|
|
$ |
26.5 |
|
|
|
|
|
Earnings per
share - diluted |
$ |
0.68 |
|
|
$ |
0.72 |
|
Plus:
Restructuring and impairment expense |
0.06 |
|
|
— |
|
Less: Tax impact
of restructuring and impairment expense |
(0.01) |
|
|
— |
|
Plus: Purchase
accounting adjustments |
0.21 |
|
|
0.18 |
|
Less: Tax impact
of purchase accounting adjustment |
(0.05) |
|
|
(0.04) |
|
Plus: Brazil tax
assessments |
(0.20) |
|
|
— |
|
Less: Tax impact
of Brazil tax assessments |
0.09 |
|
|
— |
|
Plus: Acquisition
related costs |
0.11 |
|
|
— |
|
Less: Tax impact
on acquisition related costs |
(0.02) |
|
|
— |
|
Plus: GBP forward
contract MTM |
0.18 |
|
|
— |
|
Less: Tax impact
on GBP forward contract MTM |
(0.05) |
|
|
— |
|
Less: Tax
legislative changes, net of other discrete items |
0.02 |
|
|
(0.01) |
|
Adjusted Earnings
Per Share - Diluted |
$ |
1.02 |
|
|
$ |
0.85 |
|
|
|
|
|
SCHWEITZER-MAUDUIT INTERNATIONAL, INC. AND
SUBSIDIARIESRECONCILIATION OF NON-GAAP FINANCIAL
MEASURES AND SUPPLEMENTAL DATA(Dollars in
millions, except per share amounts)
|
Three Months Ended March 31, |
|
2021 |
|
2020 |
Net income |
$ |
21.6 |
|
|
$ |
22.5 |
|
Plus: Interest
expense on debt |
7.4 |
|
|
6.9 |
|
Plus: Reversal of
interest expense on Brazil tax assessments |
(4.5) |
|
|
— |
|
Plus: Provision
for income taxes |
7.4 |
|
|
5.3 |
|
Plus:
Depreciation and amortization |
16.4 |
|
|
14.8 |
|
Plus:
Restructuring and impairment expense |
1.7 |
|
|
0.1 |
|
Plus: Inventory
write-down expense related to plant closure |
— |
|
|
— |
|
Plus: Acquisition
related costs |
3.6 |
|
|
— |
|
Plus: Income from
equity affiliates |
(1.0) |
|
|
— |
|
Plus: Other
income, net |
(1.4) |
|
|
(0.6) |
|
Plus: GBP forward
contract MTM |
5.6 |
|
|
— |
|
Plus: Reversal of
other expenses related to Brazil tax assessments |
(1.6) |
|
|
— |
|
Adjusted
EBITDA |
$ |
55.2 |
|
|
$ |
49.0 |
|
|
|
|
|
AMS adjusted
EBITDA |
$ |
32.1 |
|
|
$ |
22.7 |
|
EP adjusted
EBITDA |
37.0 |
|
|
39.0 |
|
Unallocated
adjusted EBITDA |
(13.9) |
|
|
(12.7) |
|
Adjusted
EBITDA |
$ |
55.2 |
|
|
$ |
49.0 |
|
|
|
|
|
Cash provided by
operating activities |
$ |
12.7 |
|
|
$ |
5.1 |
|
Less: Capital
spending |
(7.1) |
|
|
(7.4) |
|
Less: Capitalized
software costs |
(0.5) |
|
|
(0.7) |
|
Free Cash
Flow |
$ |
5.1 |
|
|
$ |
(3.0) |
|
|
|
|
|
|
|
|
|
|
March 31, 2021 |
|
December 31, 2020 |
|
|
|
|
Total Debt |
$ |
617.9 |
|
|
$ |
593.3 |
|
Less: Cash |
63.7 |
|
|
54.7 |
|
Net Debt |
$ |
554.2 |
|
|
$ |
538.6 |
|
Schweitzer Mauduit (NYSE:SWM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Schweitzer Mauduit (NYSE:SWM)
Historical Stock Chart
From Apr 2023 to Apr 2024